Lipopolysaccharide prevents cell death caused by glutathione depletion: Possible mechanisms of protection

Neuroscience

Volumn 114, Issue 2, 2002, Pages 361-372

  Kramer, B C ^a   Yabut, J A ^a   Cheong, J ^a   Jnobaptiste, R ^a   Robakis, T ^a   Olanow, C W ^a   Mytilineou, Catherine ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

L buthionine sulfoximine; Mesencephalic cultures; Oxidative stress; Parkinson s disease; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; BASIC FIBROBLAST GROWTH FACTOR; BUTHIONINE SULFOXIMINE; CELL PROTEIN; CYTOKINE; GLUTATHIONE; GROWTH FACTOR; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DEPLETION; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; GLIA CELL; MESENCEPHALON; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; TISSUE CULTURE;

ANIMALS; ARACHIDONIC ACID; ASTROCYTES; BRAIN; BUTHIONINE SULFOXIMINE; CELL DEATH; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; FETUS; FREE RADICAL SCAVENGERS; GLUTATHIONE; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICROGLIA; NEUROGLIA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; SUPEROXIDES; UP-REGULATION;

EID: 0036775636     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00310-X     Document Type: Article

References (73)

1. Abe K., Pan L.H., Watanabe M., Kato T., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199:1995;152-154.
2. Ahmed S.H., He Y.Y., Nassief A., Xu J., Xu X.M., Hsu C.Y., Faraci F.M. Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke. 31:2000;193-199.
3. Aschner M. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology. 19:1998;269-281.
4. Bartosz G. Peroxynitrite: mediator of the toxic action of nitric oxide. Acta Biochim. Pol. 43:1996;645-659.
5. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9:1998;259-275.
6. Benveniste E.N., Sparacio S.M., Norris J.G., Grenett H.E., Fuller G.M. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30:1990;201-212.
7. Bergmeyer, H.-U., Bernt, E., Hess, B., 1963. Lactate dehydrogenase. In: Bergmeyer, H.-U. (Ed.), Methods of Enzymatic Analysis. Academic Press, New York.
8. Bolanos J.P., Heales S.J., Land J.M., Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1995;1965-1972.
9. Bordet R., Deplanque D., Maboudou P., Puisieux F., Pu Q., Robin E., Martin A., Bastide M., Leys D., Lhermitte M., Dupuis B. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J. Cereb. Blood Flow Metab. 20:2000;1190-1196.
10. Bouvier M.M., Mytilineou C. Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J. Neurosci. 15:1995;7141-7149.
11. Bronstein D.M., Perez-Otano I., Sun V., Mullis Sawin S.B., Chan J., Wu G.C., Hudson P.M., Kong L.Y., Hong J.S., McMillian M.K. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704:1995;112-116.
12. Castano A., Herrera A.J., Cano J., Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70:1998;1584-1592.
13. Clemens J.A., Stephenson D.T., Smalstig E.B., Roberts E.F., Johnstone E.M., Sharp J.D., Little S.P., Kramer R.M. Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke. 27:1996;527-535.
14. Cocco T., Di Paola M., Papa S., Lorusso M. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radic. Biol. Med. 27:1999;51-59.
15. Cohen G., Kesler N. Monoamine oxidase and mitochondrial respiration. J. Neurochem. 73:1999;2310-2315.
16. Dawson D.A., Furuya K., Gotoh J., Nakao Y., Hallenbeck J.M. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion. J. Cereb. Blood Flow Metab. 19:1999;616-623.
17. Del Vecchio P.J., Shaffer J.B. Regulation of antioxidant enzyme expression in LPS-treated bovine retinal pigment epithelial and corneal endothelial cells. Curr. Eye Res. 10:1991;919-925.
18. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16:1996;2553-2562.
19. Dexter D.T., Sian J., Rose S., Hindmarsh J.G., Mann V.M., Cooper J.M., Wells F.R., Daniel S.E., Lees A.J., Schapira A.H., et al. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35:1994;38-44.
20. Drukarch B., Schepens E., Stoof J.C., Langeveld C.H., Van Muiswinkel F.L. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic. Biol. Med. 25:1998;217-220.
21. Engele J., Schubert D., Bohn M.C. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia. J. Neurosci. Res. 30:1991;359-371.
22. Fawcett J.W. Astrocytic and neuronal factors affecting axon regeneration in the damaged central nervous system. Cell Tissue Res. 290:1997;371-377.
23. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 25:1994;227-233.
24. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13:1993;29-37.
25. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57:1998;338-342.
26. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
27. Gruol D.L., Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15:1997;307-339.
28. Han S.K., Mytilineou C., Cohen G. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66:1996;501-510.
29. Hou J.G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69:1997;76-83.
30. Jenner P., Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47:1996;S161-170.
31. Jeohn G.H., Kong L.Y., Wilson B., Hudson P., Hong J.S. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J. Neuroimmunol. 85:1998;1-10.
32. Katsuki H., Okuda S. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46:1995;607-636.
33. Kifle Y., Monnier J., Chesrown S.E., Raizada M.K., Nick H.S. Regulation of the manganese superoxide dismutase and inducible nitric oxide synthase gene in rat neuronal and glial cells. J. Neurochem. 66:1996;2128-2135.
34. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
35. Langeveld C.H., Jongenelen C.A., Schepens E., Stoof J.C., Bast A., Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci. Lett. 192:1995;13-16.
36. Li Y., Maher P., Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 19:1997;453-463.
37. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 293:2000;607-617.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
39. Makar T.K., Nedergaard M., Preuss A., Gelbard A.S., Perumal A.S., Cooper A.J. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62:1994;45-53.
40. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:1980;890-902.
41. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
42. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51:1991;155-194.
43. Merad-Saidoune M., Boitier E., Nicole A., Marsac C., Martinou J.C., Sola B., Sinet P.M., Ceballos-Picot I. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion. Exp. Neurol. 158:1999;428-436.
44. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
45. Mokuno K., Ohtani K., Suzumura A., Kiyosawa K., Hirose Y., Kawai K., Kato K. Induction of manganese superoxide dismutase by cytokines and lipopolysaccharide in cultured mouse astrocytes. J. Neurochem. 63:1994;612-616.
46. Moore S.A., Yoder E., Murphy S., Dutton G.R., Spector A.A. Astrocytes, not neurons, produce docosahexaenoic acid (22 omega-3) and arachidonic acid (20:4 omega-6). J. Neurochem. 56:(6):1991;518-524.
47. Muller H.W., Junghans U., Kappler J. Astroglial neurotrophic and neurite-promoting factors. Pharmacol. Ther. 65:1995;1-18.
48. Mytilineou C., Han S.K., Cohen G. Toxic and protective effects of L-dopa on mesencephalic cell cultures. J. Neurochem. 61:1993;1470-1478.
49. Mytilineou C., Kokotos Leonardi E.T., Kramer B.C., Jamindar T., Olanow C.W. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J. Neurochem. 73:1999;112-119.
50. Mytilineou C., Leonardi E.K., Radcliffe P., Heinonen E.H., Han S.K., Werner P., Cohen G., Olanow C.W. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J. Pharmacol. Exp. Ther. 284:1998;700-706.
51. Nagata K., Takei N., Nakajima K., Saito H., Kohsaka S. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J. Neurosci. Res. 34:1993;357-363.
52. Oka S., Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem. 266:1991;9956-9960.
53. O'Malley E.K., Sieber B.A., Black I.B., Dreyfus C.F. Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture. Brain Res. 582:1992;65-70.
54. O'Malley E.K., Sieber B.A., Morrison R.S., Black I.B., Dreyfus C.F. Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor. Brain Res. 647:1994;83-90.
55. Park T.H., Mytilineou C. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 599:1992;83-97.
56. Perry T.L., Godin D.V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:1982;305-310.
57. Perry V.H., Hume D.A., Gordon S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience. 15:1985;313-326.
58. Peuchen S., Bolanos J.P., Heales S.J., Almeida A., Duchen M.R., Clark J.B. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52:1997;261-281.
59. Reiter C.D., Teng R.J., Beckman J.S. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J. Biol. Chem. 275:2000;32460-32466.
60. Sagara J.I., Miura K., Bannai S. Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61:1993;1672-1676.
61. Sasaki S., Shibata N., Komori T., Iwata M. iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci. Lett. 291:2000;44-48.
62. Shornick L.P., Holtzman M.J. A cryptic, microsomal-type arachidonate 12-lipoxygenase is tonically inactivated by oxidation-reduction conditions in cultured epithelial cells. J. Biol. Chem. 268:1993;371-376.
63. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
64. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:1992;128-130.
65. Stella N., Estelles A., Siciliano J., Tence M., Desagher S., Piomelli D., Glowinski J., Premont J. Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. J. Neurosci. 17:1997;2939-2946.
66. Stephenson D., Rash K., Smalstig B., Roberts E., Johnstone E., Sharp J., Panetta J., Little S., Kramer R., Clemens J. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia. 27:1999;110-128.
67. Stephenson D.T., Manetta J.V., White D.L., Chiou X.G., Cox L., Gitter B., May P.C., Sharp J.D., Kramer R.M., Clemens J.A. Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Res. 637:1994;97-105.
68. Takeshima T., Johnston J.M., Commissiong J.W. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J. Neurosci. 14:1994;4769-4779.
69. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748:1997;267-270.
70. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
71. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75:1997;1149-1163.
72. Wullner U., Seyfried J., Groscurth P., Beinroth S., Winter S., Gleichmann M., Heneka M., Loschmann P., Schulz J.B., Weller M., Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res. 826:1999;53-62.
73. Yu W.J., Liau S.S., Chin W.T., Cheng J.T. Effect of serum in medium on the expression of inducible nitric oxide synthase and superoxide dismutases in cultured C6 glioma cells. Neurosci. Lett. 261:1999;37-40.